DIC India Limited (DICIND) Fair Value & Analysis
Basic Materials · IN · Market cap ₹4.7B
Fair value as of: Jun 29, 2026
Analysis
DIC India Limited (DICIND) currently trades at ₹509.65, while our model-based Fair Value estimate is ₹321.82 — implying the stock looks roughly 36.9% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
DIC India Limited manufactures and sells printing inks and allied material in India. The company provides newspaper printing inks; gravure printing inks comprising lamination, and surface printing; solvent and water based flexo inks; specialty inks, including industrial, UV varnish, UV offset, and high-speed UV news inks; and offset printing, commercial, and packaging inks, as well as concentrates and food safe and low migration solutions. It offers lamination and solvent based adhesives. It serves newspapers, magazines, conversion agents, printing and packaging, and national and international printing and packaging establishments. The company was formerly known as Coates of India Limited and changed its name to DIC India Limited in August 2004. DIC India Limited was incorporated in 1947 and is based in Noida, India. DIC India Limited is a subsidiary of DIC Asia Pacific Pte Limited.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is DIC India Limited (DICIND) undervalued?
What is the fair value of DICIND?
What is the quality score of DICIND?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.